Nita L Seibel MD
Head, Pediatric Solid Tumor Therapeutics
Join to View Full Profile
9850 Key West AveRockville, MD 20850
Phone+1 301-765-5400
Fax+1 301-294-0897
Dr. Seibel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
National Capital ConsortiumFellowship, Pediatric Hematology/Oncology, 1984 - 1987
National Capital ConsortiumResidency, Pediatrics, 1984 - 1986
Nationwide Children's Hospital/Ohio State UniversityResidency, Pediatrics, 1981 - 1983
Ohio State University College of MedicineClass of 1981
Certifications & Licensure
OH State Medical License 1987 - 2026
MD State Medical License 1988 - 2025
VA State Medical License 1988 - 2018
DC State Medical License 1988 - 2014
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia Start of enrollment: 1996 Sep 01
Publications & Presentations
PubMed
- Phase II Study of Samotolisib in Children and Young Adults With Tumors Harboring Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Pathway Alterations: Pediatric...Theodore W Laetsch, Kathleen Ludwig, P Mickey Williams, Sinchita Roy-Chowdhuri, David R Patton
JCO Precision Oncology. 2024-09-01 - 1 citationsPalbociclib in Solid Tumor Patients With Genomic Alterations in the cyclinD-cdk4/6-INK4a-Rb Pathway: Results From National Cancer Institute-Children's Oncology Group P...Margaret E Macy, Rajen Mody, Joel M Reid, Jin Piao, Lauren Saguilig
JCO Precision Oncology. 2024-09-01 - 1 citationsPhase II study of vemurafenib in children and young adults with tumors harboring BRAF V600 mutations: NCI-COG pediatric MATCH trial (APEC1621) Arm G.Marie V Nelson, AeRang Kim, P Mickey Williams, Sinchita Roy-Chowdhuri, David R Patton
The Oncologist. 2024-08-05
Press Mentions
- Dexrazoxane Protects the Heart Long Term for Kids Being Treated for CancerMarch 16th, 2023
- FDA Committee Unanimously Rejects 131-I-Omburtamab for NeuroblastomaOctober 28th, 2022
- NCI-COG Pediatric MATCH Study Shows Benefit of Genetic Screening in Refractory TumorsApril 4th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
